U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07683585) titled 'Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention' on May 18.
Brief Summary: This prospective randomized open-label study aims to compare the effectiveness of two dual antihypertensive therapy regimens in patients with arterial hypertension and coronary artery disease after elective percutaneous coronary intervention (PCI) with coronary artery stenting.
Patients requiring dual antihypertensive therapy will be randomized to receive either an angiotensin receptor blocker (ARB) combined with a thiazide diuretic or an ARB combined with a dihydropyridine calcium channel block...